NEKTAR THERAPEUTICS (NKTR) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$55.2M

Net Income/Loss (FY2025)

-$164.1M

Total Assets (FY2025)

$280.4M

Total Equity (FY2025)

$89.8M

Cash Flows from Operating Activities (FY2025)

-$208.5M

Source: NEKTAR THERAPEUTICS 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.